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Purpose: To compare the clinical outcome of different multifocal intraocular lenses (IOLs) 
based on information reported in the international literature.
Methods: All comparative clinical trials that involved implanting at least one multifocal IOL 
in patients with cataract or presbyopia were extracted from the literature. Clinical outcomes 
included uncorrected near visual acuity, uncorrected distance visual acuity, visual acuity, 
spectacle independence, and halos. Random effects meta-analyses were conducted to compare 
outcomes for the different IOL types.
Results: Twenty papers were identified describing 11 monofocal IOLs and 35 multifocal IOLs 
(19 diffractive, including 12 ReSTOR®, 14 refractive, and two accommodative) patient cohorts. 
Multifocal and monofocal uncorrected distance visual acuity was 0.165 (0.090–0.240) and 0.093 
(0.088–0.098), respectively. Compared with monofocal IOLs, multifocal IOLs produced better 
uncorrected near visual acuity (0.470 [0.322–0.618] versus 0.141 [0.131–0.152]; P , 0.0001), 
resulting in higher spectacle independence (incidence rate ratio [IRR] 3.62 [2.90–4.52]; 
P , 0.0001). Compared with refractive multifocal IOLs, diffractive multifocal IOLs produced 
a similar uncorrected distance visual acuity (0.105 [0.098–0.111] versus 0.085 [0.029–0.140]; 
P # 0.78, not significant) and better uncorrected near visual acuity (0.217 [0.118–0.317] ver-
sus 0.082 [0.067–0.098]; P , 0.0001) resulting in higher spectacle independence (IRR 1.75 
[1.24–2.48]; P , 0.001). Compared with other multifocal IOLs, ReSTOR produced a better 
uncorrected distance visual acuity (0.067 [0.059–0.076] versus 0.093 [0.088–0.098]; P , 0.0001) 
and better uncorrected near visual acuity (0.064 [0.046–0.082] versus 0.141 [0.131–0.152]; 
P , 0.006), resulting in higher spectacle independence (IRR 2.06 [1.26–1.36]; P , 0.004). Halo 
incidence rates with different types of multifocal implants did not differ significantly.
Conclusion: Multifocal IOLs provide better uncorrected near visual acuity than monofocal 
IOLs, leading to less need for spectacles. Multifocal IOL design might play a role in postsur-
gical outcome, because better results were obtained with diffractive lenses. ReSTOR showed 
better uncorrected near visual acuity, uncorrected distance visual acuity, and higher spectacle 
independence rates compared with other multifocal IOLs.
Keywords: multifocal implants, meta-analysis, uncorrected near visual acuity, uncorrected 
distance visual acuity, spectacle independence, patient satisfaction
Introduction
An estimated 20.5 million Americans older than 40 years have cataract in at least one eye.1 
While cataract is the leading cause of blindness worldwide,2,3 most populations in devel-
oped Western countries have access to cataract surgery (eg, 6.1 million [5.1%] of Ameri-
can citizens have pseudophakia/aphakia). The total number of Americans with cataract 
is predicted to increase to 30.1 million by 2020, of whom 9.5 million are expected to Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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have pseudophakia.1 More than 80% of patients regain good 
best-corrected visual acuity (visual acuity $ 8/10) after cataract 
surgery, depending on other ocular pathology and duration of   
follow-up.4–8
Traditional intraocular lenses (IOLs) are monofocal, and 
after implantation most patients need spectacles, at least for 
near vision. Multifocal IOLs are intended to free patients 
from spectacles after presbyopia or cataract surgery by apply-
ing the principle of simultaneous vision.9 Early multifocal 
IOLs were associated with loss of clarity and poor accom-
modation, reduced contrast sensitivity, and complaints of 
halos and glare. Improvements in intraocular lens technology 
have enabled cataract patients to be implanted with multifocal 
IOLs to provide better visual acuity at various distances and 
a degree of spectacle independence.10
Today, multifocal IOLs produce functional near and 
distance vision and acceptable levels of patient satisfaction 
in everyday practice.11–14 However, reviews on the clinical 
consequences of multifocal implantations are rare.15
Many IOL clinical trials have been performed, but to our 
knowledge, no relevant meta-analysis has been reported. 
Our objective was to conduct a meta-analysis of published 
comparative clinical trials in which at least one patient group 
was implanted with multifocal implants bilaterally.
Materials and methods
Bibliographic research
An extensive literature review was performed through Medline 
and most recently updated on June 30, 2009. The following 
multifocal IOL names were used as keywords: Acrilisa® (Carl 
Zeiss Meditec, La Rochelle, France), Diffractiva® (HumanOp-
tics, Erlangen, Germany), Rayner® (Rayner Intraocular Lenses 
Ltd., Hove, UK), ReSTOR® (Alcon Inc., Fort Worth, TX), 
Rezoom® (Abbott Medical Optics, Santa Ana, CA), and 
Tecnis® (Abbott Medical Optics), together with keywords 
focusing on comparative clinical trials, ie, “cataract surgery”, 
“comparison”, “multifocal”, and “visual acuity”. Abstracts 
were scrutinized and full articles ordered and analyzed in depth 
if they reported comparative studies in adult patients.
Inclusion criteria were publication in the French or Eng-
lish language, bilateral implantation of the same IOL, use of 
Tecnis, Acrilisa, Rezoom, Diffractiva, Rayner, or ReSTOR 
implants, and publication from 2000 onwards.
Exclusion criteria included comparison of different 
populations, double implantation in the same eye, double 
reporting, explantation of the implant, in vitro studies, 
no aggregated results, noncomparative studies, unilateral 
implantation, and use of a refractive procedure (eg, Lasik).
All available data from the selected articles were extracted 
and tabulated with respect to each study’s identity, its design 
(prospective or retrospective, randomized or not randomized), 
IOL names and type (monofocal or   multifocal; diffractive or 
refractive), reasons for IOL implantation, number of patients 
at baseline and at final follow-up, average follow-up dura-
tion, final overall patient satisfaction, spectacle dependency, 
uncorrected distance visual acuity, uncorrected intermediate 
visual acuity, uncorrected near visual acuity, and the number 
of patients reporting “halos”.
Data analysis
Outcome variables of the study were as follows:
•	 Uncorrected distance and near visual acuities converted to 
LogMAR equivalents, as described in detail elsewhere,16 
when expressed in a different unit.
•	 Freedom from spectacles (independence), separately 
analyzed for distance and reading spectacles. It should 
be noted, however, that most studies combined all types 
of spectacles to express an overall need for spectacles, 
instead of providing specific information on distance 
versus reading spectacles.
•	 Patient satisfaction; given that variations between studies 
existed, to assess patient satisfaction, we standardized 
measurements according to the range of the measure-
ments reported in each study.
•	 Presence of halo, which was reported using various defi-
nitions among the studies. Prevalence (presence versus 
absence of halos) was reported in this study.
We compared the aforementioned outcomes for the 
following subgroups of IOL implants: monofocal versus 
multifocal implants; diffractive versus refractive multifo-
cal implants (data were insufficient to assess the effects 
of accommodative implants separately); and ReSTOR 
versus other multifocal implants. ReSTOR outcomes were 
highlighted because they relate to a new type of multifocal 
apodized IOL.
statistical analysis
We used random effects models17,18 to obtain pooled estimates 
of visual acuity with 95% confidence intervals (CI), and 
tested for statistically significant differences between the 
estimates with respect to each IOL subgroup.
We used random effects Poisson regression models to 
compare the effect of IOL implant type on the need for spec-
tacles. The outcome of interest was the number of patients 
needing spectacles, with study effects taken into account by 
the random effects component of the models. The exposure Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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variable for the Poisson models was defined as the product 
of the number of patients receiving a given implant and the 
average period of follow-up for each study. Similarly, we 
used random effects Poisson regression models to compare 
overall patient satisfaction and the presence of halo across 
subgroups of implants.
Forest plots were used to present the results. The lines 
represent the estimates from different studies and their CI. 
The boxes represent graphically the weight given to each 
study in calculating the pooled estimate for a given outcome. 
This weight is essentially a function of the number of patients 
followed up in different studies.
Results
Bibliographic research
Initial electronic searches identified 197 titles or abstracts. 
Complete copies of all possibly relevant papers were obtained, 
according to the criteria specified earlier. Fifty-one papers 
appeared to meet the inclusion criteria for this review.
Twenty of the 51 studies were included in the meta-
analysis. The excluded 31 papers finally did not meet the 
inclusion and exclusion criteria. Reasons for exclusion were, 
as follows: a different IOL in each eye (n = 7); reimplanta-
tion in one eye (n = 1); no comparison IOL (n = 6); double 
reporting (n = 4); comparison of different populations (n = 1); 
comparisons of monofocal IOLs (n = 2); either no data or 
aggregated data (n = 8); results after Lasik or another pro-
cedure (n = 2); and in vitro results (n = 1).
Descriptive data analysis
Twenty studies were included in the meta-analysis,19–38 of 
which 16 were prospective studies (80%) and four were 
retrospective (Table 1). Eight (50%) of the prospective stud-
ies were randomized. Data were collected from 46 patient 
groups, comprising 35 multifocal implant groups (76.1%) 
and 11 monofocal implant groups (23.9%). Among the mul-
tifocal implant groups, 19 were implanted with diffractive 
IOLs, 14 with refractive IOLs, and two with accommodative 
IOLs. ReSTOR was implanted in 12 of these groups (34.3%). 
Accommodative implants were studied in 26 patients only, 
and so were not analyzed as a specific group. Uncorrected 
distance vision acuity was described for 30 groups and near 
vision acuity for 23 groups.
All except six publications reported patient satisfaction 
as percentages of patients “satisfied” or “very satisfied”. 
Four papers isolated “patient satisfaction with vision” from a 
broader assessment of “overall satisfaction”. One paper rated 
satisfaction on a scale from 0 to 10 (maximal satisfaction). 
Finally, one paper used a questionnaire yielding a global 
measure of overall satisfaction that included a validated 
“VF-14 index of visual function”.
Fourteen (70%) of the 20 publications assessed spec-
tacle independence, expressed in most cases as the number, 
or percentage, of patients who at the end of the follow-up 
period needed spectacles for reading or distance vision. 
Other studies asked patients how often they wore spectacles 
and gave them the response options of “always”, “occasion-
ally”, or “never”. Distance vision (spectacle independence) 
was not stated by 10 studies, and only four studies gave both 
distance and near vision, by indicating patients requiring the 
respective correction spectacles. Visual disturbances, which 
could be night-time halos, moderate halos, or severe halos, 
were reported by 10   studies (50%). Table 2 summarizes the 
characteristics of all 20 publications included in this meta-
analysis and provides references to them.
Visual acuity
Table 3 shows pooled estimates of random effects, with 95% 
CI, for uncorrected distance and near visual acuity (LogMAR 
scale) after monofocal and multifocal IOL implants. Separate 
estimates are shown for diffractive and refractive multifocal 
implants and for ReSTOR.
Table 4 shows that multifocal and monofocal uncorrected 
distance visual acuity was 0.165 and 0.093, respectively. 
Between the multifocal implants, there was no statistically 
significant uncorrected distance visual acuity difference 
(P = 0.78), or between diffractive IOLs (average LogMAR 
0.105) and refractive IOLs (average LogMAR 0.085). How-
ever, uncorrected distance visual acuity was significantly 
better with ReSTOR (average   LogMAR 0.067) as compared 
with other multifocal implants (P , 0.001). Table 4 also 
shows that uncorrected near visual acuity was significantly 
better (P , 0.001) after multifocal implants (average Log-
MAR 0.141) than monofocal IOLs (average LogMAR 0.470). 
Moreover, with multifocal implants, uncorrected near visual 
acuity was significantly better (P = 0.002) with diffractive 
IOLs (average LogMAR 0.082) than refractive IOLs (aver-
age LogMAR 0.217). Furthermore, uncorrected near visual 
acuity was significantly better (P = 0.006) after ReSTOR 
implants (average LogMAR 0.064) than after all other mul-
tifocal IOLs. Forest plots of uncorrected near and distance 
visual acuity are reported in Figures 1–4.
Freedom from spectacles
Table 5 shows the results of random effects Poisson regression 
models comparing the incidence of no spectacle require-Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Table 1 Characteristics, references, and available results of the published studies
Reference Design IOL Trt Satisfaction Spectacle  
classification
Halo
Bi et al19 P resTOr vs Acrysof  
sn60AT
n satisfaction with  
reading acuity
spectacle independence n
Chiam et al20 P resTOr vs  
rezoom
Y Overall satisfaction spectacle independence Y
Toto et al21 P resTOr vs  
Tecnis
Y n
souza et al22 P resTOr vs Acrysof  
sA60AT
n Y
Vingolo et al23 r resTOr vs Acrysof  
sA60AT
n.m. spectacle independence Y
Alfonso et al24 P resTOr sA60D3 vs  
resTOr sn60D3
n Overall  
satisfaction
near distance  
spectacle independence
n
Chiam et al25 P resTOr vs Acrysof  
sA60AT
n.m. % of patients completely  
or very satisfied
spectacle independence Y
Pepose et al26 P resTOr vs  
rezoom vs  
Crystalens
n % of patients completely  
or very satisfied
near and distance  
spectacle independence
n
Mester et al27 P Tecnis vs Array Y % of patients completely  
or very satisfied
spectacle independence Y
Brydon et al28 r Array vs si-30nB n VF14 index n
Chen et al29 r Monofocal Acrysof vs  
Array
n % of patients satisfied  
with results
spectacle independence n
sen et al30 P Array vs si-40nB Y % of patients completely  
or very satisfied
Y
Javitt et al31 P Array vs AMO Y satisfaction level graded  
from 0 to 10
spectacle independence n
Cochener et al38 P resTOr vs Acrysof  
MA60BM
n spectacle independence Y
Alio et al37 P Crystalens (AT45) vs  
Array sA40n vs  
Acritec twinset
n Y
Cillino36 P Ar40 (AMO) vs  
Array sA40n vs  
rezoom (AMO) vs  
Tecnis ZM900
Y Overall satisfaction Full spectacle  
independence
Y
Zelichowska et al35 r resTOr sn60D3 vs  
rezoom
n.m. n
Barisic et al34 P Tecnis multifocal vs  
rezoom
Y spectacle independence n
Chang-David33 P resTOr vs  
rezoom
n spectacle independence Y
Martinez-Palmer et al32 P Tecnis Z9000 vs  
Tecnis ZM900 vs  
rezoom vs  
Acritec twinset
Y Full spectacle  
independence
n
Abbreviations: n.m., not mentioned; P, prospective; r, retrospective; Trt, treatment affected at random; vs, versus; Y, yes; n, no; iOL, imtraocular lens implant.
ment after different IOL implants. In general, patients with 
multifocal IOL implants, especially those with diffractive 
implants, were most likely not to need spectacles. Estimates 
varied for near and distance vision spectacles, compared 
with all spectacles combined, with most estimates specific to 
the two spectacle types not reaching statistical significance, 
probably because too few specific data were available for 
analysis. Overall, however, patients with multifocal implants 
were 3.6 times more likely not to need spectacles (incidence 
rate ratio [IRR] 3.62, 95% CI: 2.90–4.52).
Diffractive IOL implants were associated with a 
1.75-times higher likelihood of spectacle independence (IRR 
1.75, 95% CI: 1.24–2.48) than refractive implants. Also, 
patients implanted with ReSTOR had a more than two-fold 
higher incidence of spectacle independence compared with 
other multifocal IOLs (IRR 2.06, 95% CI: 1.26–3.36).Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Table 2 Characteristics of the implants included in the 20 articles
# Reference IOL Type MIOL type Follow-up  
(weeks)
Patients (n)
3 Bi et al19 resTOr
Acrysof 
sn60AT
MiOL
Mono
Diffractive 12
12
20
18
5 Chiam et al20 resTOr
rezoom
MiOL Diffractive 24 50
MiOL refractive 24 50
8 Toto et al21 resTOr MiOL Diffractive 24 14
Tecnis ZM 900 MiOL Diffractive 24 14
9 souza et al22 resTOr MiOL Diffractive 16 24
Acrysof 
sA60AT
Mono 16 15
10 Vingolo et al23 resTOr 
sA60D3
MiOL Diffractive 24 50
Acrysof 
sA60AT
Mono 24 20
11 Alfonso et al24 resTOr 
sA60D3
MiOL Diffractive 24 325
resTOr 
sn60D3
MiOL Diffractive 24 335
19 Blaylock41 resTOr 
sn60D3
MiOL Diffractive 8 40
Acrysof 
sA60AT
Mono 8 40
25 Pepose et al26 resTOr MiOL Diffractive 20 12
rezoom MiOL refractive 20 14
Crystalens 
(AT45)
MiOL Accommodative 20 14
32 Mester et al27 Tecnis ZM900 MiOL Diffractive 24 23
Array sA40 MiOL refractive 24 24
36 Brydon et al28 Array (sA40n) MiOL refractive 11 15
si-30nB Mono 10 13
38 Chen et al29 Monofocal 
Acrysof
Mono nm 20
Array MiOL refractive nm 20
41 sen et al30 Array (sA40n) MiOL refractive 4 35
si-40nB Mono 4 40
43 Javitt et al31 Array (sA40n) MiOL refractive 12 123
PhacoFlex 
si40nB
Mono 12 109
53 Cochener et al38 resTOr MiOL Diffractive 21 499
Acrysof 
MA60BM
Mono 21 173
55 Alio et al37 Crystalens AT45 MiOL Accommodative 48 12
Array sA40n MiOL refractive 48 16
Acritec twinset MiOL Diffractive 48 12
56 Cillino et al36 Ar40 (AMO) Mono 48 15
Array sA40n MiOL refractive 48 16
rezoom (AMO) MiOL refractive 48 15
Tecnis ZM900 MiOL Diffractive 48 16
57 Zelichowska et al35 resTOr  
sn60D3
MiOL Diffractive 24 23
rezoom MiOL refractive 24 23
59 Barisic et al34 Tecnis multifocal MiOL Diffractive 24 50
rezoom MiOL refractive 24 50
60 Chang-David33 resTOr MiOL Diffractive 24 15
rezoom MiOL refractive 24 15
61 Martinez-Palmer et al32 Tecnis Z9000 Mono 12 24
Tecnis ZM900 MiOL Diffractive 12 26
rezoom MiOL refractive 12 32
Acritec twinset MiOL Diffractive 12 32
Abbreviations: iOL, intraocular lens implant; MiOL, multifocal intraocular lens implant; nm, not mentioned.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Table 3 Characteristics of the 46 groups
Patients (n)  
(total patients)
Follow-up  
(weeks)
Average UDVA 
(LogMAR)
Average UNVA  
(LogMAR)
Satisfaction  
rate
Need for spectacle 
(all spectacles)
Monofocal  
groups 
n 
Mean # of 
patients (sD)  
(min–max)
(486) 
11
44.3 (50.8) 
(13–273)
10 
16.9 (12.4) 
(4–48)
5 
0.27 (0.25) 
(0.11–0.7)
5 
0.47 (0.124)
(0.3–0.61)
8 
0.8 (0.23) 
(0.31–0.99)
7 
0.78 (0.22) 
(0.45–0.96)
Multifocal  
groups 
n 
Mean (sD) 
(min–max)
(2055) 
35 
58.7 (106.5) 
(12–499)
34 
24.4 (12.5) 
(4–48)
25 
0.09 (0.08) 
(-0.066–0.245)
18 
0.15 (0.098)
(0.013–0.403)
23 
0.87 (0.08) 
(0.64–0.99)
19 
0.31 (0.2) 
(0.08–0.67)
Diffractive  
groups 
n 
Mean (sD)  
(min–max)
(1580) 
19 
83.2 (139.3) 
(12–499)
19 
23 (10.3) 
(8–48)
14 
0.109 (0.065) 
(0.03–0.245)
9 
0.091 (0.054) 
(0.013–0.156)
11 
0.90 (0.06) 
(0.82–0.99)
11 
0.2 (0.13) 
(0.08–0.56)
Refractive  
groups 
n 
Mean (sD) 
(min–max)
(448) 
14 
32 (29) 
(14–123)
13 
24.8 (14.7) 
(4–48)
9 
0.074 (0.088)
(-0.066–0.207)
7 
0.232 (0.099) 
(0.11–0.403)
11 
0.93 (0.09) 
(0.64–0.94)
8 
0.47 (0.14) 
(0.3–0.67)
ReSTOR  
groups 
n 
Mean (sD) 
(min–max)
(1408)
12 
117.3 (168) 
(12–499)
12 
20.5 (5.5) 
(8–24)
8 
0.069 (0.031) 
(0.03–0.13)
7 
0.08 (0.055) 
(0.013–0.15)
8 
0.9 (0.07)
(0.82–0.99)
6 
0.16 (0.06) 
(0.08–0.27)
Abbreviations: UDVA, uncorrected distance visual acuity; UnVA, uncorrected near visual acuity; sD, standard deviation; min, minimum; max, maximum.
Table 4 random effects pooled estimates of uncorrected distance and near visual acuity for iOL implants
IOL implant Distance visual acuity Near visual acuity
Mean LogMAR 95% CI P* Mean LogMAR 95% CI P*
Monofocal 0.165 0.090–0.240 ,0.001 0.470 0.322–0.618 ,0.001
Multifocal, all 0.093 0.088–0.098 0.141 0.131–0.152
Multifocal, 
diffractive
0.105 0.098–0.111 0.78 0.082 0.067–0.098 0.002
Multifocal, 
refractive
0.085 0.029–0.140 0.217 0.118–0.317
resTOr 0.067 0.059–0.076 ,0.001 0.064 0.046–0.082 0.006
Notes: *P values for statistical test of the significance of the differences between monofocal versus multifocal, diffractive versus refractive, and ReSTOR other multifocal 
iOL implants, respectively. 
Abbreviations: IOL, intraocular lens; CI, confidence interval.
Patient satisfaction and halo
Results of patient satisfaction and presence of halo analyses 
are shown in Tables 5 and 6. No statistically significant dif-
ferences between implant types were found for patient satis-
faction or halo reports. In most cases, point estimates (IRRs) 
were close to the null value (1.0), except between diffractive 
versus refractive IOL implants with regard to halo. Diffrac-
tive implants were associated with a lower incidence rate of 
halo as compared with refractive implants (IRR 0.71, 95% 
CI: 0.48–1.05), but the difference did not reach statistical 
significance (P = 0.087).
Discussion
Our study compared vision outcomes after multifocal IOL 
or monofocal IOL implants, and outcomes after multifocal 
implants differing in physical properties and other charac-
teristics. In this meta-analysis, because we found very few 
trials comparing head to head monofocal IOLs, we made the Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
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decision to use monofocal IOL arms as a common arm to 
do indirect comparisons among multifocal IOLs. We did not 
compare the different types of monofocal IOLs, because this 
was not our objective and because the experimental design 
was not appropriate for us to do so.
Although we identified an important number of relevant 
studies (n = 20), it should be noted that most did not   randomize 
treatments, which could be considered as poor evidence 
reporting. However, this can be explained by certain ethical 
constraints. Randomization is acceptable in the early develop-
ment of an IOL, from the patient’s point of view, because the 
associated benefit–risk ratio has to be quantified. Subsequently, 
however, it is much more difficult to promise patients spectacle 
independence when treatments are randomized in a clinical trial 
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Figure 1 Uncorrected distant visual acuity: random effects pooled LogMAr estimates for monofocal vs multifocal intraocular lens implants. The y-axis denotes the estimates 
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and knowing that only patients given a multifocal IOL implant 
can enjoy freedom from spectacles. This explains why most 
trials analyzed by this meta-analysis were not randomized.
We found better uncorrected distance visual acuity follow-
ing multifocal IOL implants than after monofocal implants, 
which was unexpected from an optics standpoint. It might 
be that surgeons implanting multifocal IOLs promised their 
patients freedom from spectacles, although this did not apply to 
monofocal implants. Perhaps they then performed more precise 
biometric assessments after the multifocal IOLs in order to 
ensure that the patients would not need spectacles. This would 
explain the better uncorrected distance visual acuity findings.
Patient satisfaction was high for all implants, with no 
difference observed between IOLs. On the top of this ceiling 
effect, it must be recalled that satisfaction reports were not 
obtained in a uniform manner across studies, which was likely 
to engender high uncontrolled variability. Also, satisfaction 
questions concerned surgical outcomes and did not refer to the 
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Figure 2 Uncorrected distant visual acuity: random effects pooled LogMAr estimates for diffractive, refractive, and resTOr multifocal intraocular lens implants. The y-axis 
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Figure 3 Uncorrected near visual acuity (VA): random effects pooled LogMAr estimates for monofocal vs multifocal intraocular lens implants. The y-axis denotes the 
estimates obtained in different studies as well as the combined (pooled) estimate.
IOLs implanted. Patients undergoing simple cataract surgery 
always express high levels of satisfaction because their cor-
rected visual acuity improves dramatically. Hence, an outcome 
questionnaire dedicated to refraction evaluation, such as the 
NEI-RQL-42, would be more appropriate to capture a patient’s 
perceived benefit of being free from spectacles.39,40
The main limitation of our study was the distribution 
of patients between the clinical trials of the different IOL 
implants. In particular, the numerically superior diffractive 
multifocal IOLs was especially due to a high number of 
patients implanted with ReSTOR as compared with the 
alternative diffractive implant, Tecnis, which was studied in 
almost 10 times fewer patients than ReSTOR. Also, the total 
number of patients recruited in clinical trials of all refractive 
multifocal IOL implants was half that for ReSTOR. Given the 
aforementioned figures, it would appear that our statistical 
analysis was more powerful with regard to objective findings 
for ReSTOR than for the other multifocal IOLs when taken Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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Figure 4 Uncorrected near visual acuity: random effects pooled LogMAr estimates for diffractive, refractive, and resTOr multifocal iOL implants. The y-axis denotes the 
estimates obtained in different studies as well as the combined (pooled) estimate.
Table 5 random effects Poisson regression estimates for comparison of the probability (incidence) of independence from no distance, 
reading, and all spectacles combined for different subgroups of iOL implants
IOL implant Distance spectacles Reading spectacles All spectacles
IRR 95% CI IRR 95% CI IRR 95% CI
Monofocal 1.00 reference 1.00 reference 1.00 reference
Multifocal, all 1.69 1.06–2.70 1.37 1.02–1.84 3.62 2.90–4.52
Multifocal diffractive  1.54 0.36–6.61 2.61 0.82–8.29 1.75 1.24–2.48
Multifocal refractive 1.00 reference 1.00 reference 1.00 reference
resTOr* not estimable** 1.51 0.43–5.24 2.06 1.26–3.36
Notes: *Comparison between ReSTOR other multifocal IOL implants; **Insufficient data for estimating the IRR. 
Abbreviations: IOL, intraocular lens; CI, confidence interval; IRR, incidence rate ratio.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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separately. Another limitation was the variability of measure-
ment parameters, especially with respect to spectacle indepen-
dence which was not expressed similarly across studies.
To our knowledge, no previous meta-analysis has been 
applied to the present outcomes with multifocal implants. 
The single existing review article15 did not involve statistical 
analysis. Consequently, we could not compare our results 
with other scientific sources.
On the basis of the present results, we can conclude that 
multifocal IOLs offer patients better near uncorrected visual 
acuity than do monofocal implants. Also, ReSTOR provided 
significantly better visual acuity than other multifocal IOLs.
Spectacle independence was achieved more frequently with 
multifocal implants than monofocal IOLs, and by multifocal 
diffractive implants than refractive IOLs. ReSTOR patients 
also experienced greater freedom from spectacles than patients 
implanted with other multifocal IOLs. The number of patients 
observed was insufficient to achieve statistical significance with 
respect to types of spectacles required (near or distance vision). 
Also, statistical significance was not attained for patient satisfac-
tion or halo reports. A trend (P = 0.087) was observed, suggesting 
fewer halos with multifocal diffractive implants compared with 
refractive IOLs. Hence, the design of an implant could also play 
a role in the outcome following a multifocal IOL implant.
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